Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Phase II Randomized Controlled Trial of Naïve T Cell Depletion for Prevention of Chronic Graft-Versus-Host Disease in Children and Young Adults

NCT03779854 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT03779854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03779854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Phase II Randomized Controlled Trial of Naïve T Cell Depletion for Prevention of Chronic Graft-Versus-Host Disease in Children and Young Adults
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 29, 2019
Completion date
August 31, 2027
Enrollment
45 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute biphenotypic leukemia, acute leukemia, acute leukemia of ambiguous lineage, acute lymphoblastic leukemia, acute undifferentiated leukemia, allogeneic hematopoietic stem cell transplantation recipient, blastic plasmacytoid dendritic cell neoplasm, blasts under 25 percent of bone marrow nucleated cells, blasts under 5 percent of bone marrow nucleated cells, burkitt leukemia, chronic monocytic leukemia, lymphoblastic lymphoma, mast cell leukemia, mixed phenotype acute leukemia, myelodysplastic syndrome with excess blasts-1, myelodysplastic syndrome/acute myeloid leukemia, myeloproliferative neoplasm